6-(4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY)-1-(4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTYL)-3,4-DIHYDRO-2(1H)-QUINOLINONE
UNII H9SHS3U3SJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butyl)-3,4-dihydro-2(1h)-quinolinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H9SHS3U3SJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 865792-18-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H45N9O2 GVMLJEUDNKNZAH-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butyl)-3,4-dihydro-2(1h)-quinolinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.